Gene · 55869
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells. | Int J Mol Sci | 2021 | 34639012 | PubTator, text mining | PubMed |
| An Update on the Current Genomic Landscape of Breast Implant-Associated Anaplastic Large Cell Lymphoma. | Cancers (Basel) | 2021 | 34638403 | PubTator, text mining | PubMed |
| Comparing the Effect of Multiple Histone Deacetylase Inhibitors on SSTR2 Expression and [111In]In-DOTATATE Uptake in NET Cells. | Cancers (Basel) | 2021 | 34638389 | PubTator, text mining | PubMed |
| Novel Molecular Subtypes and Related Score Based on Histone Acetylation Modification in Renal Clear Cell Carcinoma. | Front Cell Dev Biol | 2021 | 34631694 | PubTator, text mining | PubMed |
| N-acetyl l-aspartate and Triacetin modulate tumor suppressor MicroRNA and class I and II HDAC gene expression induce apoptosis in Glioblastoma cancer cells in vitro. | Life Sci | 2021 | 34626605 | PubTator, text mining | PubMed |
| Development of potent dual PDK1/AurA kinase inhibitors for cancer therapy: Lead-optimization, structural insights, and ADME-Tox profile. | Eur J Med Chem | 2021 | 34624821 | PubTator, text mining | PubMed |
| In-Silico Analysis of Chromatin Modifiers and Profiling of Histone Deacetylases (HDAC's) in Human Oral Cancer. | Chonnam Med J | 2021 | 34621637 | PubTator, text mining | PubMed |
| Role of microRNAs in COVID-19 with implications for therapeutics. | Biomed Pharmacother | 2021 | 34601190 | PubTator, text mining | PubMed |
| Targeting Histone Modifications in Breast Cancer: A Precise Weapon on the Way. | Front Cell Dev Biol | 2021 | 34595180 | PubTator, text mining | PubMed |
A methyltransferase-like 14/miR-99a-5p/tribble 2 positive feedback circuit promotes cancer stem cell persistence and radioresistance via histone deacetylase 2-mediated epigenetic modulation in esophageal squamous cell carcinoma. | Clin Transl Med | 2021 | 34586732 | PubTator, text mining | PubMed |
| Alternative lengthening of telomeres is mechanistically linked to potential therapeutic vulnerability in the stem-like subtype of gastric cancer. | Clin Transl Med | 2021 | 34586731 | PubTator, text mining | PubMed |
| Examining the Developmental Trajectory of an in Vitro Model of Mouse Primordial Germ Cells following Exposure to Environmentally Relevant Bisphenol A Levels. | Environ Health Perspect | 2021 | 34585602 | PubTator, text mining | PubMed |
| Improved HDAC Inhibition, Stronger Cytotoxic Effect and Higher Selectivity against Leukemias and Lymphomas of Novel, Tricyclic Vorinostat Analogues. | Pharmaceuticals (Basel) | 2021 | 34577551 | PubTator, text mining | PubMed |
| Interaction of (+)-Strebloside and Its Derivatives with Na+/K+-ATPase and Other Targets. | Molecules | 2021 | 34577146 | PubTator, text mining | PubMed |
| Proteasomal Degradation of Zn-Dependent Hdacs: The E3-Ligases Implicated and the Designed Protacs That Enable Degradation. | Molecules | 2021 | 34577077 | PubTator, text mining | PubMed |
| Cashew Nut Shell Liquid (CNSL) as a Source of Drugs for Alzheimer's Disease. | Molecules | 2021 | 34576912 | PubTator, text mining | PubMed |
| Interrogating Epigenome toward Personalized Approach in Cutaneous Melanoma. | J Pers Med | 2021 | 34575678 | PubTator, text mining | PubMed |
| Vorinostat (SAHA) and Breast Cancer: An Overview. | Cancers (Basel) | 2021 | 34572928 | PubTator, text mining | PubMed |
| Stationed or Relocating: The Seesawing EMT/MET Determinants from Embryonic Development to Cancer Metastasis. | Biomedicines | 2021 | 34572451 | PubTator, text mining | PubMed |
| Marine Power on Cancer: Drugs, Lead Compounds, and Mechanisms. | Mar Drugs | 2021 | 34564150 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55869/papers?page=48